These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 9501671
21. Natural history and prognostic factors of IgA nephropathy presented with isolated microscopic hematuria in Chinese patients. Shen P, He L, Li Y, Wang Y, Chan M. Nephron Clin Pract; 2007; 106(4):c157-61. PubMed ID: 17596724 [Abstract] [Full Text] [Related]
22. Favorable outcome of renal transplantation in patients with IgA nephropathy. Andresdottir MB, Hoitsma AJ, Assmann KJ, Wetzels JF. Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657 [Abstract] [Full Text] [Related]
23. IgA nephropathy: the presence of familial disease does not confer an increased risk for progression. Izzi C, Ravani P, Torres D, Prati E, Viola BF, Guerini S, Foramitti M, Frascà G, Amoroso A, Ghiggeri GM, Schena FP, Scolari F. Am J Kidney Dis; 2006 May; 47(5):761-9. PubMed ID: 16632014 [Abstract] [Full Text] [Related]
24. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy. Bazzi C, Rizza V, Paparella M, Casellato D, Napodano P, Olivieri G, D'Amico G. J Nephrol; 2009 May; 22(3):387-96. PubMed ID: 19557716 [Abstract] [Full Text] [Related]
25. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy. Komatsu H, Fujimoto S, Hara S, Sato Y, Yamada K, Eto T, Nakao H. Ren Fail; 2005 May; 27(1):45-52. PubMed ID: 15717634 [Abstract] [Full Text] [Related]
26. An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy. van der Boog PJ, van Kooten C, van Seggelen A, Mallat M, Klar-Mohamad N, de Fijter JW, Daha MR. Nephrol Dial Transplant; 2004 Oct; 19(10):2487-93. PubMed ID: 15252166 [Abstract] [Full Text] [Related]
27. The impact of sex in primary glomerulonephritis. Cattran DC, Reich HN, Beanlands HJ, Miller JA, Scholey JW, Troyanov S, Genes, Gender and Glomerulonephritis Group. Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409 [Abstract] [Full Text] [Related]
28. Clinical course and prognostic factors of clinical early IgA nephropathy. Shen P, He L, Huang D. Neth J Med; 2008 Jun; 66(6):242-7. PubMed ID: 18689907 [Abstract] [Full Text] [Related]
29. Useful indicators for performing renal biopsy in adult patients with isolated microscopic haematuria. Shen P, He L, Jiang Y, Wang C, Chen M. Int J Clin Pract; 2007 May; 61(5):789-94. PubMed ID: 17362478 [Abstract] [Full Text] [Related]
30. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation. Moriyama T, Nitta K, Suzuki K, Honda K, Horita S, Uchida K, Yumura W, Tanabe K, Toma H, Nihei H, Yamaguchi Y. Clin Transplant; 2005 May; 19 Suppl 14():41-8. PubMed ID: 15955168 [Abstract] [Full Text] [Related]
31. Prognostic factors in immunoglobulin-A nephropathy. Muthukumar T, Fernando ME, Jayakumar M. J Assoc Physicians India; 2002 Nov; 50():1354-9. PubMed ID: 12583461 [Abstract] [Full Text] [Related]
32. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy. Trimarchi H, Muryan A, Young P, Forrester M, Iotti A, Pereyra H, Lombi F, Seminario O, Alonso M, Iotti R. Medicina (B Aires); 2007 Nov; 67(5):445-50. PubMed ID: 18051227 [Abstract] [Full Text] [Related]
33. Features of IgA nephropathy in preschool children. Utsunomiya Y, Kado T, Koda T, Okada S, Hayashi A, Fukawaza A, Nakagawa T, Kanzaki S, Kasagi T. Clin Nephrol; 2000 Dec; 54(6):443-8. PubMed ID: 11140804 [Abstract] [Full Text] [Related]
34. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China. Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H. Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258 [Abstract] [Full Text] [Related]
35. [Renal vascular lesions and the occurrence of hypertension in patients with IgA nephropathy]. Boulahrouz R, Stanescu C, Charasse C, Ang KS, Le Cacheux P, Leonetti F, Rioux N, Ramee MP, Simon P. Arch Mal Coeur Vaiss; 2004 Jun; 97(7-8):782-5. PubMed ID: 15506066 [Abstract] [Full Text] [Related]
36. Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study. Li PK, Leung CB, Chow KM, Cheng YL, Fung SK, Mak SK, Tang AW, Wong TY, Yung CY, Yung JC, Yu AW, Szeto CC, HKVIN Study Group. Am J Kidney Dis; 2006 May; 47(5):751-60. PubMed ID: 16632013 [Abstract] [Full Text] [Related]
37. Acute kidney injury in immunoglobulin A nephropathy: potential role of macroscopic hematuria and acute tubulointerstitial injury. Kveder R, Lindic J, Ales A, Kovac D, Vizjak A, Ferluga D. Ther Apher Dial; 2009 Aug; 13(4):273-7. PubMed ID: 19695058 [Abstract] [Full Text] [Related]
38. Enhanced urinary adiponectin excretion in IgA-nephropathy patients with proteinuria. Shimotomai T, Kakei M, Narita T, Koshimura J, Hosoba M, Kato M, Komatsuda A, Ito S. Ren Fail; 2005 Aug; 27(3):323-8. PubMed ID: 15957550 [Abstract] [Full Text] [Related]
39. Cumulative excretion of urinary podocytes reflects disease progression in IgA nephropathy and Schönlein-Henoch purpura nephritis. Hara M, Yanagihara T, Kihara I. Clin J Am Soc Nephrol; 2007 Mar; 2(2):231-8. PubMed ID: 17699418 [Abstract] [Full Text] [Related]
40. Asymptomatic proteinuria and/or haematuria in 265 Malaysian adults. Cheong IK, Kong N, Segasothy M, Morad Z, Menon P, Suleiman AB. Med J Malaysia; 1991 Jun; 46(2):150-4. PubMed ID: 1839419 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]